[Vasopeptidase inhibition: a new pharmacological principle in the treatment of hypertension and cardiac insufficiency]

Dtsch Med Wochenschr. 2001 Nov 23;126(47):1342-7. doi: 10.1055/s-2001-18567.

[Article in German]

Authors

R Kolloch¹, E Offers

Affiliation

¹ Medizinische Klinik, Krankenanstalten Gilead, Bielefeld. kolloch@gilead.de

PMID: 11719860
DOI: 10.1055/s-2001-18567

No abstract available

Publication types

Review

MeSH terms

Angiotensin-Converting Enzyme Inhibitors / pharmacology*
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Animals
Atrial Natriuretic Factor / pharmacology*
Atrial Natriuretic Factor / physiology
Blood Pressure / drug effects*
Endothelium, Vascular / metabolism
Heart Failure / drug therapy*
Heart Failure / physiopathology
Humans
Hypertension / drug therapy*
Hypertension / physiopathology
Neprilysin / antagonists & inhibitors*
Receptors, Angiotensin / metabolism
Renin-Angiotensin System / drug effects
Renin-Angiotensin System / physiology

Substances

Angiotensin-Converting Enzyme Inhibitors
Receptors, Angiotensin
Atrial Natriuretic Factor
Neprilysin